As of 2025-09-15, the Relative Valuation of Ocular Therapeutix Inc (OCUL) is (24.01) USD. This relative valuation is based on P/E multiples. With the latest stock price at 12.81 USD, the upside of Ocular Therapeutix Inc based on Relative Valuation is -287.4%.
The range of the Relative Valuation is (22.57) - (24.49) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 16.2x - 19.7x | 18.8x |
| Forward P/E multiples | 18.1x - 21.3x | 19.8x |
| Fair Price | (22.57) - (24.49) | (24.01) |
| Upside | -276.2% - -291.2% | -287.4% |
| Date | P/E |
| 2025-09-10 | -10.48 |
| 2025-09-09 | -10.24 |
| 2025-09-08 | -10.20 |
| 2025-09-05 | -10.92 |
| 2025-09-04 | -10.20 |
| 2025-09-03 | -10.39 |
| 2025-09-02 | -10.20 |
| 2025-08-29 | -9.80 |
| 2025-08-28 | -10.05 |
| 2025-08-27 | -9.89 |
| 2025-08-26 | -9.89 |
| 2025-08-25 | -9.53 |
| 2025-08-22 | -9.87 |
| 2025-08-21 | -9.74 |
| 2025-08-20 | -9.60 |
| 2025-08-19 | -9.75 |
| 2025-08-18 | -9.88 |
| 2025-08-15 | -10.13 |
| 2025-08-14 | -10.16 |
| 2025-08-13 | -10.03 |
| 2025-08-12 | -10.01 |
| 2025-08-11 | -10.08 |
| 2025-08-08 | -9.80 |
| 2025-08-07 | -9.87 |
| 2025-08-06 | -10.03 |
| 2025-08-05 | -9.63 |
| 2025-08-04 | -9.91 |
| 2025-08-01 | -9.57 |
| 2025-07-31 | -9.30 |
| 2025-07-30 | -9.36 |
| 2025-07-29 | -9.43 |
| 2025-07-28 | -9.70 |
| 2025-07-25 | -9.80 |
| 2025-07-24 | -9.57 |
| 2025-07-23 | -9.60 |
| 2025-07-22 | -9.27 |
| 2025-07-21 | -9.24 |
| 2025-07-18 | -9.10 |
| 2025-07-17 | -9.14 |
| 2025-07-16 | -9.03 |
| 2025-07-15 | -8.90 |
| 2025-07-14 | -9.05 |
| 2025-07-11 | -8.85 |
| 2025-07-10 | -8.89 |
| 2025-07-09 | -8.64 |
| 2025-07-08 | -7.96 |
| 2025-07-07 | -7.71 |
| 2025-07-03 | -7.72 |
| 2025-07-02 | -7.59 |
| 2025-07-01 | -7.31 |